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Abstract
Background: Fatigue is recognized as a disabling symptom in many chronic conditions including
rheumatic disorders such as rheumatoid arthritis (RA) and lupus. Fatigue in osteoarthritis (OA) is
not routinely evaluated and has only been considered in a very limited number of studies. To date,
these studies have focused primarily on patients with OA under rheumatological care, which
represent the minority of people living with OA. The purpose of this study was to increase our
understanding of the fatigue experience in community dwelling people with OA.
Methods: In 2004, 8 focus groups were conducted with 28 men and 18 women (mean age 72.3)
with symptomatic hip or knee OA recruited from a population-based cohort. Participants
completed a self-administered questionnaire, which included demographics, measures of OA
severity (WOMAC), depression (CES-D) and fatigue (FACIT). Sessions were audio taped and
transcribed verbatim. Two researchers independently reviewed the transcripts to identify themes.
Findings were compared and consensus reached.
Results: Mean pain, disability, depression and fatigue scores were 8.7/20, 27.8/68, 15.4/60, and
30.9/52, respectively. Participants described their fatigue as exhaustion, being tired and "coming up
against a brick wall". Participants generally perceived fatigue as different from sleepiness and
distinguished physical from mental fatigue. Factors believed to increase fatigue included OA pain
and pain medications, aging, various types of weather and poor sleep. Mental health was identified
as both affecting fatigue and being affected by fatigue. Participants described fatigue as impacting
physical function, and their ability to participate in social activities and to do household chores.
Rest, exercise, and avoiding or getting assistance with activities were cited as ways of coping.
Participants generally did not discuss their fatigue with anyone except their spouses.
Conclusion:  Participants with OA described experiencing notable amounts of fatigue and
indicated that it had a substantial impact on their lives. Further research is required to better
understand the role of fatigue in OA in order to identify strategies to reduce its impact.
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Background
Arthritis is one of the most common chronic conditions
in the population[1], resulting in substantial social and
economic costs [2]. Due to the aging of the population,
the prevalence and impact of this disease is projected to
greatly increase [3,4]. Osteoarthritis (OA) is the most
common form of arthritis, accounting for approximately
75% of the disease [5] and ranking among the top ten
causes of disability worldwide [6]. In 2003, Canadians liv-
ing with arthritis identified fatigue as a research priority
[7], but to date, very little is known about the role of this
symptom in OA.
Fatigue is a common, non-specific, symptom experienced
by most people at some point during their lives. It is the
enduring, subjective sensation of generalized tiredness or
exhaustion [8]. It is also conceptualized variously as wea-
riness, weakness and depleted energy [9]. Fatigue is distin-
guished from sleepiness [9]and can be divided into that
which is a primary complaint or a secondary complaint
due to a known disease [10].
Many chronic physical illnesses are associated with
fatigue, including cancer [11], and multiple sclerosis [12].
Fatigue has also been recognized as an important symp-
tom in rheumatic disorders such as systemic lupus ery-
thematosus and rheumatoid arthritis (RA) [13,14].
Fatigue is often identified as one of the most challenging
aspects of chronic disease [8,15]. It is a disabling symp-
tom that has been shown to have a substantial impact on
patients' self-care activities [16] and overall quality of life
[17,18].
Fatigue in OA is not routinely evaluated and has only
been considered in a limited number of studies. To date,
these studies have focused primarily on patients with OA
under rheumatological care, which represents the minor-
ity of people living with OA. However, among this sub-
group with OA, fatigue levels have been reported as
similar to those of patients with RA [19-24]. Wolfe et al
[20] reported that approximately 40% of OA patients
have substantial fatigue and, as for RA, fatigue in OA is
associated with pain, sleep disturbance and depressed
mood [20,23]. Gignac et al [25] recently reported that
adults with moderate OA participating in focus groups
describe their fatigue as debilitating and occasionally
activity restricting.
The purpose of our qualitative study was to increase our
understanding of the fatigue experience in community-
dwelling individuals with hip and knee OA. This study is
the first step in a program of research examining fatigue in
OA and how it relates to OA symptoms such as pain and
disability, as well as mood and sleep. Better understand-
ing fatigue and how it relates to these symptoms has the
potential to lead to better management strategies and
improved quality of life for people living with OA.
Methods
Most participants were recruited from an existing popula-
tion-based cohort of individuals with at least moderately
severe symptomatic hip or knee OA residing in two coun-
ties of Ontario, Canada. Extensive details on cohort
design have been published elsewhere [26,27]. Briefly, eli-
gible participants in the two counties were English-speak-
ing adults aged 55+ years who indicated on a screening
survey, conducted between January 1996 and October
1998, that they had at least moderately severe hip or knee
complaints defined as meeting all of the following crite-
ria: (1) difficulty in the past 3 months with each of stair
climbing, arising from a chair, standing and walking, and
(2) self-reported swelling, pain, or stiffness in any joint
lasting ? 6 weeks in the past 3 months and (3) indication
on a homunculus that a hip and/or knee was "trouble-
some". To limit the study to those with OA, individuals
were deemed ineligible if they indicated they had been
diagnosed with or were prescribed medication for inflam-
matory arthritis.
As recruitment for the fatigue focus groups was done
simultaneously with recruitment for analogous groups on
pain, data on participation rates for the two types of
groups could not be separated. Individuals with other
conditions closely linked to fatigue or pain were not eligi-
ble. One hundred and fifty-five cohort members were
asked to participate in the focus groups, as well as 5 indi-
viduals who were not part of the original cohort. These lat-
ter individuals were between the ages of 55 and 63 years
and were included to assist in capturing a broader range of
experiences, as the youngest members of the cohort were
64 years of age at the time of recruitment. These "new"
participants were recruited from arthritis patient organiza-
tions, other research groups or had indicated a willingness
to participate in research at dissemination events. These
participants met the same eligibility criteria as for the
cohort. Of the 160 individuals in total thus asked to par-
ticipate, 87 (54.4%) attended one of the sessions, 6
(3.9%) did not show for their scheduled session, 48
(31.0%) were unavailable and 19 (12.3%) cancelled with
the intention of rescheduling, but the groups were com-
pleted prior to this occurring. Participants were scheduled
to attend either a fatigue or pain focus group based on
their availability, as well as their sex, age and urban/rural
status so as to ensure that approximate balance on these
variables was achieved.
We conducted focus groups on fatigue in OA, rather than
individual interviews, in order to encourage participants
to discuss and compare their experiences, allowing for a
comprehensive description of osteoarthritis fatigue to beBMC Musculoskeletal Disorders 2008, 9:63 http://www.biomedcentral.com/1471-2474/9/63
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captured. Focus groups were comprised of 3–8 partici-
pants and were conducted until we felt "saturation" (no
new themes identified) was reached. Groups were con-
ducted separately with men and women in order to
encourage open discussion around topics that partici-
pants might be more hesitant to discuss in a mixed gender
environment, such as the impact of fatigue on mood and
relationships. Groups were also age-stratified (> 75, 65–
75, < 65), where possible. Participants provided
informed, written consent before participation. The
Research Ethics Board of Sunnybrook and Women's Col-
lege Health Sciences Centre approved the study (Refer-
ence Number 091-2004).
All focus groups were conducted between May and Octo-
ber 2004 and lead by a single moderator. Identical ques-
tions were asked of each group (Table 1) in sessions
lasting 2–2.5 hours. Each focus group was audio taped,
transcribed verbatim and imported into N6 software. At
the start of each focus group, participants completed a
questionnaire that included age, sex, education and race,
as well as the following measures:
Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC)
Data were collected to assess OA severity in participants
using the 5-item pain and 17-item physical functioning
subscales, which assess the amount of pain and functional
limitation experienced in the past week while performing
various activities [28]. The WOMAC has been shown to be
valid, reliable and responsive [28-30].
Functional Assessment of Chronic Illness Therapy Fatigue 
Scale (FACIT)
This 13- item instrument provides a measure of overall
fatigue and was included to supplement the qualitative
fatigue data collected and aid in assessing the severity of
fatigue experienced by participants. The FACIT assesses
the extent of self-reported tiredness, weakness and diffi-
culty conducting usual activities due to fatigue in the pre-
vious week. The FACIT-F has been used and validated in a
variety of populations, including inflammatory arthritis
[31,32].
Center for Epidemiologic Studies Depression Scale (CES-
D)
This 20-item instrument measures the frequency of
depressive symptoms in the previous week [33] and was
included to further characterize participants in light of the
strong associations between depression and fatigue. The
CES-D has been validated across a variety of demographic
characteristics, including in the elderly [34,35].
Analyses
Focus group transcripts were independently reviewed by
two of the study authors (JDP, MRF) to identify and code
distinct themes. Themes were compared and discussed
until consensus was reached. A list of themes and exem-
plars of each were then identified. Descriptive statistics
(percentages, means, medians etc.) were generated to
summarize the demographic characteristics of the cohort
as well as scores on the questionnaire measures. These
analyses were conducted using Statistical Package for the
Social Sciences (SPSS) version 14.0.
Results
The eight focus groups included 28 (60.9%) women and
18 (39.1%) men (Table 2). All participants were Cauca-
sian and ranged in age from 56 to 88 years (mean ± SD =
72.3 ± 7.7 years). Exactly half (50.0%) had a highschool
education with 26.2% and 23.8% having less than and
greater than a high school education, respectively. Partici-
pants had moderate WOMAC pain and physical function-
ing scores (Table 3). CES-D scores were right-skewed, with
a mean and median of 15.4 and 14.5, respectively. Seven-
teen participants (37.0%) had CES-D scores over 16,
which are considered indicative of significantly depressed
mood. FACIT fatigue scores were approximately normally
distibuted with a mean and median of 31.
Five main themes were identified to summarize the focus
groups: fatigue characteristics, factors affecting fatigue,
Table 1: Focus Group Questions
1. Tell us about the fatigue you experience with your arthritis. Do you ever feel fatigued? What is it like?
2. When you think of fatigue and sleepiness, do you see them as different? How?
3. What do you think causes your fatigue?
4. How does your arthritis affect your fatigue?
5. What, if anything, has an effect on your fatigue? What makes you more fatigued/less fatigued?
6. What, if anything, has been the impact of this fatigue on your life?
7. What changes or modifications have you made to cope with your fatigue?
8. Have you noticed any relationship between your fatigue and how you feel including changes in other symptoms or changes in emotions or mood? 
[If they see as related: Tell me more, does one come first, does one lead to the other or one cause the other for you?]
9. Do you talk about your fatigue with others? With who? What do you tell them?
10. We all have experiences of fatigue in our lives due to various problems. What makes your arthritis fatigue different from other kinds of fatigue?BMC Musculoskeletal Disorders 2008, 9:63 http://www.biomedcentral.com/1471-2474/9/63
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impact of fatigue, methods of coping with fatigue and dis-
cussions about fatigue with others.
Theme 1: Fatigue characteristics
Most participants indicated that they had experienced
fatigue; they used a variety of terms to describe their
fatigue, including "tired", "exhausted", "worn out", "weak-
ness" and "loss of energy". One participant characterized
fatigue as "coming up against a brick wall" and another said
it was like "somebody threw a pail of water over my head". The
majority of participants indicated that they felt fatigue and
sleepiness were different. One stated, "I think it's just a
complete exhaustion and ... it's not like you're going to sleep but
you just have to sit down and you just can't keep going."
Another said, "Yeah, I felt the same way, when I get really
fatigued it's not that I feel I'm tired, but I feel that if I don't go
lie down, I'll fall down." Several participants indicated that
they felt that there were different types of fatigue. The
terms 'mental' and 'physical' fatigue were used. The per-
ceived differences between these were described by one
participant: "...physical fatigue is associated more with, I'd
say, aches and pains in their limbs and muscles and backs and
legs and so on...But the mental fatigue is something much dif-
ferent. You just feel absolutely drained out and you can't focus
...It does affect your thinking and how you approach different
things and all of that, your ability to understand things. I think
mental fatigue is much worse than physical fatigue. Physical
fatigue you can get over it in a short time, but mental fatigue it
may stay with you 2 or 3 days, maybe longer." Several partic-
ipants also distinguished what they felt was arthritis-
related fatigue from their other experiences with fatigue,
as illustrated by the following statement: "I find that when
you are fatigued from when you are doing work I mean you
sleep, you wake up and you feel refreshed, but when you are
fatigued from arthritis and you have rested or tried to rest,
you're still fatigued when you wake up, you're still not there."
Theme 2: Factors affecting fatigue
Participants linked fatigue to a variety of factors. It was
described as a consequence of aging and as due to various
types of weather, including rainy, cold weather as well as
heat, humidity and extreme weather changes. Participants
disagreed with media reports and physicians who indi-
cated that weather should not affect their arthritis symp-
toms. One participant questioned whether the
relationship between fatigue and the weather might be
related to depression, saying, "I think sometimes too that
when the weather's bad and the rain and you're really hurting
and that tiredness comes on it's almost like part of a depres-
sion?" Activity level, doing too much or too little, was also
cited as a cause of fatigue. It was also linked to arthritis, in
that it takes longer and requires more energy to do things
because of arthritis and this then leads to fatigue. Pain was
mentioned quite often as causing fatigue. One participant
noted "..I think it's wearing if you're in pain, it's very tiring. "
Additionally, medications taken to relieve pain were also
said to cause fatigue: "I do think that the pills we keep taking
to keep the pain down...make you feel yucky and tired and
draggy."
Emotions and mood, including frustration, anger, stress
and depression were additionally linked to fatigue by par-
ticipants. However, mood was discussed in relation to
arthritis generally, and specifically to pain, such that there
seemed to be the suggestion of a pathway leading to
fatigue, including the potential for feedback among symp-
Table 2: Socio-Demographic Characteristics (N = 46)
Characteristic Mean ± Standard Deviation or N (%)
Gender Female 28 (60.9%)
Age (years) 72.3 ± 7.7
Education* < highschool 11 (26.2%)
highschool 21 (50.0%)
> highschool 10 (23.8%)
*N = 42 for education
Table 3: Health Status Measures*
Scale Possible Scores Mean ± Standard Deviation Median Range
WOMAC pain 0–20 8.7 ± 3.9 8.0 0–18
WOMAC physical function 0–68 27.8 ± 11.6 25.0 7–48
CES-D 0–60 15.4 ± 8.9 14.5 2–44
FACIT 0–52 30.9 ± 9.0 30.5 14–47
* FACIT is scored so that lower scores indicate greater fatigue. All other scales are scored so that a higher score indicates greater symptom 
severity. WOMAC = Western Ontario and McMaster Universities Osteoarthritis Index; CES-D = Center for Epidemiologic Studies Depression 
Scale; FACIT = Functional Assessment of Chronic Illness Therapy Fatigue ScaleBMC Musculoskeletal Disorders 2008, 9:63 http://www.biomedcentral.com/1471-2474/9/63
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toms. For example, one participant stated, "I would say it's
the pain comes first, then because of the pain you get tired. Pain
is really debilitating for me anyway, and I get really tired and
then because I'm so tired and because then I don't have the
energy to do the things that I want to do, let alone the things
that need to be done or should be done. Then I tend to get
depressed or upset with myself and then I think it just begets
more tiredness and it's a downhill slide. " Similarly another
participant said, "I think the pain level ...grows and ... you feel
fatigued, you feel stressed and stress brings on fatigue and
...then you get that stress tension..." Some participants also
stated that they experienced sleep difficulties at night due
to arthritis-related pain and that this made them tired dur-
ing the day.
Theme 3: Impact of fatigue
Focus group participants indicated that fatigue had a sub-
stantial impact on their lives. We heard that fatigue was
"all consuming" and "totally overwhelming". Emotional
responses to fatigue were widely discussed. We heard that
living with fatigue made participants irritable, cranky,
frustrated, angry and depressed. For example, one partici-
pant explained, " But the reverberation has [been] for me,
more than anything else, for lack of a better word, depression.
I'm not able...to focus, I'm not able to...work- I grew up on a
farm. I've led a very physical life as well as a life of the mind
too... But to me that fatigue thing, it is exhaustion like you said,
you know, that...you can't put one foot in front of the other any
more, but part of it is the exhaustion of the spirit or the exhaus-
tion of the mind." One participant compared pain and
fatigue, stating, "But do you find that the tiredness, like it's
pain, it takes over our thinking and your thought process, and
you almost shut down?" Fatigue was also identified as affect-
ing physical functioning. Participants indicated that it
took them longer to do things, they required more rest
and they were exhausted more easily. Several indicated
that they had to limit or give up activites such as volunteer
work, chores and lesiure or social activities. One female
participant discussed at length the difficulty she had on a
trip to the zoo with her husband, at a time when she felt
her arthritis was particularly bad: "I couldn't wait until I got
to the next bench, I was having a terrible time, and he was quite
exasperated. Well if you're going to be like that, why don't we
just go home? Well no, that's not the point, the point is ...
you're involving me in something that I can't partake in because
I don't have the energy, I'm tired, I'm so fatigued I can't even
think straight." We also heard that for some participants,
fatigue had affected their relationships. One participant
stated, "I think in relationships perhaps it's relationships of
friends that maybe has suffered the most because by the time the
evening comes around [I'm] too tired to go and do any visit-
ing."
Theme 4: Methods of coping with fatigue
Participants discussed a variety of coping methods for
dealing with fatigue, including resting, taking naps or hot
baths, getting help with chores and using assistive devices.
Pacing of activities was cited several times. For example,
one participant noted, "Yes, that's one thing, dividing jobs up
instead of trying to do everything all at once, if you can do only
one load of laundry today, fine." Exercise was also men-
tioned as a means to reduce fatigue. One participant
explained, ".. you feel one hundred percent better really so
good just to lay on the floor and just to do minor exercises just
for fifteen, twenty minutes, and you'd be amazed at the energy
you get after that." Participants also discussed distracting
oneself, visiting family and friends and cognitive ways of
coping, including the acceptance of fatigue. One partici-
pant explained, "...Because we find that if you're in cheerful
company and there's something to laugh about, you can forget
your fatigue and you can forget your pains."
Theme 5: Discussion about fatigue with others
When our focus group participants were asked whom they
spoke to about their fatigue, there were relatively few
responses; spouses were the only people mentioned. One
participant stated, "The only one I talk and compare notes
[with] is with my husband. Then I say... you feel the same way,
then I must be normal, you know you wonder... is it my imagi-
nation or is it normal, or is there something wrong with me ...I
worry about when I don't know what's going on." A male par-
ticipant similarly stated that he only spoke to his wife and
that, "Nobody else wants to hear about it."
Discussion
Although generally not perceived as an important symp-
tom in OA, the majority of our focus group participants
with lower extremity OA clearly indicated that they had
experienced notable fatigue. They made distinctions
between what they perceived as arthritis-related fatigue
and other experiences with fatigue, linking fatigue to OA
pain and mental health and suggesting close inter-rela-
tionships among these symptoms. They indicated that
fatigue had made a significant impact on their lives, affect-
ing mental health and physical functioning and causing
them to limit or give up activities.
Although the primary goal of our study was to collect
qualitative data on fatigue in OA, we did collect quantita-
tive data on the extent of fatigue experienced by partici-
pants in the previous week using the FACIT fatigue scale.
The mean score of 30.9 (± 9.0) for our participants is
approximately equal to mean scores of RA patients at
baseline in two clinical trials (29.2 ± 11.1, 27.9 ± 11.0)
[31]. It is also between baseline clinical trial scores of ane-
mic (23.9 ± 12.6) and non-anemic (40.9 ± 9.8) cancer
patients (higher scores = less fatigue) [11]. Although there
are differences between these populations, these relativeBMC Musculoskeletal Disorders 2008, 9:63 http://www.biomedcentral.com/1471-2474/9/63
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scores appear to support our qualitative findings that par-
ticipants experienced a salient amount of fatigue.
Perhaps one of the reasons fatigue has largely been
ignored in OA, is that OA is generally viewed as non-
inflammatory and therefore unlikely to be associated with
fatigue. However, this viewpoint negates the substantial
body of literature that supports the links our focus group
participants made between pain, mental health and
fatigue. A 2003 structured, evidence-based review [36]
concluded that there is an association between pain and
fatigue and that the available evidence suggests that it may
be an etiological relationship. Similarly, associations
between mental health and fatigue have consistently been
shown to be quite strong, especially for depression
[20,37-39]. In OA specifically, Wolfe et al [20] found that
pain was the strongest predictor of fatigue in OA, explain-
ing 25% of the variance in fatigue scores in multivariate
regression analyses. Depression was also a major predictor
and was almost three times more common in persons
with significant fatigue.
Several participants in our focus groups discussed sleep
difficulties when asked about factors affecting fatigue,
which is in accord with previous research [20]. Although
most participants had indicated that they believed there
was a difference between sleepiness and fatigue, some
used the word "tired" when discussing sleep problems.
This term is somewhat ambiguous in that it could refer to
either sleepiness or fatigue. Pigeon et al [9] suggest defin-
ing sleepiness as drowsiness, sleep propensity, and
decreased alertness, and fatigue as weariness, weakness,
and depleted energy. The use of the word "tired" is a
potential limitation of several available fatigue measures,
including the FACIT.
Some of our focus group participants suggested that there
were different types of fatigue, using the terms mental and
physical fatigue. There is literature to suggest that there are
multiple manifestations or dimensions of fatigue, includ-
ing physical/neuromuscular, emotional/affective and
mental/cognitive components [40], with varying predic-
tors and consequences. To our knowledge, the potential
for multiple dimensions of fatigue in OA has not yet been
investigated.
A notable proportion, 37%, of our focus group partici-
pants had scores on the CES-D suggestive of significantly
depressed mood, using the standard score cut-off of 16.
There are challenges to measuring depression in the eld-
erly [41] and in those with chronically painful conditions
[42,43] such as the common inclusion of somatic symp-
toms in depression measures. Additionally, measures of
depression include items that are included in measures of
fatigue. Although fatigue and depression frequently occur
together, fatigue is neither sensitive nor specific to the
diagnosis of depression [38] and studies have demon-
strated that fatigue and depression are distinct [44,45]. It
is not possible to discern from our focus groups if depres-
sion or fatigue scores were inflated due to these issues.
However, we do feel based on our participants' discus-
sions that the fatigue they described was not solely a
symptom of depression.
Co-morbidity is also unlikely to explain our study find-
ings. Potential participants with co-morbidities closely
linked to fatigue or pain were ineligible. Further, all but 5
participants had been part of an ongoing cohort study for
the previous 7–9 years and by necessity of their continued
participation are likely to be relatively healthy. This is sup-
ported by data collected in the year prior to the focus
groups in which 54% (n = 22) of the 41 focus group par-
ticipants with available data reported no other health con-
ditions. Co-morbidities reported by the remaining
participants were diabetes, hypertension, heart and lung
problems and 27% of participants reported only one of
these. Obesity is also a potential contributing factor to
fatigue [46] and our cohort data indicate that of the 37
focus group participants with available height and weight
data, 17 were obese. This is typical of the hip and knee OA
population and we felt that any further exclusions would
unduly jeopardize the generalizability of our findings.
A strength of our study is the use of participants recruited
from a population-based cohort. The majority of research
on fatigue in OA has utilized rheumatology clinic sam-
ples, which represent a small fraction of people with OA.
However, as is the norm in qualitative research our find-
ings are based on a small number of participants and
should be replicated, although our participants do reflect
the demographics of the hip and knee OA population.
Additional qualitative and quantitative research will be
needed to further clarify the role of fatigue in OA.
Conclusion
Participants in our focus groups clearly described experi-
encing significant amounts of fatigue and indicated that it
had a substantial impact on their lives. They highlighted
emotional consequences and impacts on daily activities
such as chores, as well as leisure and social activities. Bet-
ter understanding the ways in which arthritis leads to dis-
ability and participation restriction has the potential to
lead to new management strategies and to improve qual-
ity of life for those living with OA. Our findings represent
an early step in increasing our understanding of fatigue in
OA and support the small body of literature that suggests
it may be an important symptom. Further research will be
required in order to fully substantiate the role of fatigue
and the associated clinical implications in OA as well as
the relative contributions of factors discussed by our par-BMC Musculoskeletal Disorders 2008, 9:63 http://www.biomedcentral.com/1471-2474/9/63
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ticipants such as pain and depression, as well as obesity
and co-morbidity. This will require research that incorpo-
rates larger sample sizes and longitudinal quantitative
data. Many individuals living with arthritis never discuss
their condition with their physicians and, although our
participants discussed a variety of coping methods for
fatigue, they did not generally discuss their fatigue with
others. Individuals living with OA need to be encouraged
to discuss all of their symptoms with their physicians, so
that they are more likely to receive appropriate clinical
attention.
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